ExodusPoint Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

ExodusPoint Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,577	Closed	-$1.51M	–	2922
2021 Q2	$1.51M	Buy	+44,577	New	+$1.14M	0.02%	804
2021 Q1	–	Sell	-11,132	Closed	-$321K	–	2824
2020 Q4	$321K	Buy	+11,132	New	+$280K	﹤0.01%	1512
2020 Q3	–	Sell	-36,357	Closed	-$1.09M	–	2407
2020 Q2	$1.09M	Buy	36,357 +28,908	+388%	+$1.04M	0.03%	700
2020 Q1	$234K	Buy	+7,449	New	+$259K	0.01%	728

ExodusPoint Capital Management's CNST Position: Q3 2021 in Review

ExodusPoint Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 44,577 shares — an estimated $1.51M sold.

ExodusPoint Capital Management first reported a position in CNST in Q1 2020 and held it in 4 quarters. The position peaked at $1.51M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

ExodusPoint Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 44,577 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.51M.
ExodusPoint Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 4 quarters.
ExodusPoint Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.51M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.